$RXMD Offers a Fresh Buying Opp in New Bull Trend
RXMD
Of course there will be some folks wanting to bank some profits here -- the stock was up as much as 135% this month alone, and is still up over 70% in November. But the technical action suggests a new, fresh bullish trend now underway, meaning that the opportunity here will be to take advantage of pullbacks.
The fundamental trend has changed as well, with the company recently reporting a breakout quarter in Q3 and guiding Q4 to the moon.
Progressive Care Reports October 2019 Performance: Q4 on Record Pace with Expanding Margins
Press Release | 11/19/2019
MIAMI, FL, Nov. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to report another month of exceptional growth and expanding margins. October sales and prescriptions filled set a new record performance pace for Q4 results.
“The annualized pace we set in October equates to new records across the board as we continue to see broad-based top-line expansion on improving margins,” stated S. Parikh Mars, Progressive Care CEO. “Our $3.4 million in overall sales for October is an understatement because it leaves out the cash flows we took in during the month related to third-party billing activity. With all factors included, the number of gross billing would be closer to $4.2 million. And our 46k prescriptions filled puts Q4 on pace to handily surpass our breakout Q3 performance already. Execution continues to be tremendous, and I am very proud of our talented and dedicated team.”
Of course there will be some folks wanting to bank some profits here -- the stock was up as much as 135% this month alone, and is still up over 70% in November. But the technical action suggests a new, fresh bullish trend now underway, meaning that the opportunity here will be to take advantage of pullbacks.
The fundamental trend has changed as well, with the company recently reporting a breakout quarter in Q3 and guiding Q4 to the moon.
Progressive Care Reports October 2019 Performance: Q4 on Record Pace with Expanding Margins
Press Release | 11/19/2019
MIAMI, FL, Nov. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to report another month of exceptional growth and expanding margins. October sales and prescriptions filled set a new record performance pace for Q4 results.
“The annualized pace we set in October equates to new records across the board as we continue to see broad-based top-line expansion on improving margins,” stated S. Parikh Mars, Progressive Care CEO. “Our $3.4 million in overall sales for October is an understatement because it leaves out the cash flows we took in during the month related to third-party billing activity. With all factors included, the number of gross billing would be closer to $4.2 million. And our 46k prescriptions filled puts Q4 on pace to handily surpass our breakout Q3 performance already. Execution continues to be tremendous, and I am very proud of our talented and dedicated team.”
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.